DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer

Medicine and Dentistry

• Polymerase 100%
• DNA Mismatch Repair 60%
• Base Excision Repair 50%
• In Vitro 40%
• Colorectal Cancer 40%
• Temozolomide 40%
• Xenograft 20%
• Nucleotide 20%
• DNA Polymerase 20%
• Chemoprophylaxis 10%
• Cancer Cell 10%
• Cell Culture 10%
• Combination Therapy 10%
• Tumor Progression 10%
• Alkylating Antineoplastic Agent 10%
• SCID Mouse 10%
• Cancer Inhibition 10%
• Colon Cancer 10%
• DNA Ligase 10%
• In Silico 10%
• Development 10%
• Colon Cancer Cell Line 10%
• Cancer Therapy 10%
• Clonogenic Assay 10%
• Drug 10%
• Chemotherapeutic Agent 10%
• Growth 10%
• Colon Tumor 10%
• DNA Alkylation 10%
• Motivation 10%
• Female 10%

Biochemistry, Genetics and Molecular Biology

• DNA Mismatch Repair 60%
• Base Excision Repair 50%
• Nucleotide 20%
• DNA Polymerase 20%
• Cancer Cell 10%
• Electric Potential 10%
• SCID Mouse 10%
• Tumor Progression 10%
• Cell Culture 10%
• Development 10%
• Small Molecule 10%
• Computer Model 10%
• Growth Inhibition 10%
• Growth 10%
• DNA Ligase 10%
• Clonogenic Assay 10%
• DNA Alkylation 10%
• Motivation 10%
• DNA 10%

Immunology and Microbiology

• Mismatch Repair 60%
• Xenograft 20%
• Cell Culture 10%
• SCID Mouse 10%
• Cancer Cell 10%
• Growth Inhibition 10%
• Computer Model 10%
• Electric Potential 10%
• Growth 10%
• Colon Cancer Cell Line 10%
• Development 10%
• Colon 10%
• DNA Alkylation 10%
• Clonogenic Assay 10%